Vitae Pharmaceuticals, Inc 4 SEC Filings

Filed On	Filing
25 Oct 2016	Form 4: Gregg Richard, Chief Science Officer Returned 228,274 shares to the issuer ($4.79M) · Disposed of 106,453 Employee Stock Option (Right to Buy) (Disposition to Issuer) ($1.34M)
25 Oct 2016	Form 4: Rowland Charles A Jr, Director Disposed of 37,000 Stock Option (Right to Buy) (Disposition to Issuer) ($421K)
25 Oct 2016	Form 4: Leonard John M., Director Disposed of 30,000 Stock Option (Right to Buy) (Disposition to Issuer) ($337K)
25 Oct 2016	Form 4: Gunderson Robert V Jr, Director Disposed of 26,832 shares (Tender Offer) ($563K) · Disposed of 51,525 Stock Option (Right to Buy) (Disposition to Issuer) ($656K)
25 Oct 2016	Form 4: Sable Carole, Chief Medical Officer Disposed of 150,000 Stock Option (Right to Buy) (Disposition to Issuer) ($1.57M)
25 Oct 2016	Form 4: Hatfield Jeffrey S., Director Disposed of 244,996 shares (Tender Offer) ($5.14M) · Disposed of 448,736 Employee Stock Option (Right to Buy) (Disposition to Issuer) ($5.91M)
25 Oct 2016	Form 4: Hayden Donald J Jr, Director Disposed of 55,182 Stock Option (Right to Buy) (Disposition to Issuer) ($706K)
25 Oct 2016	Form 4: Junius Daniel M, Director Disposed of 20,000 Stock Option (Right to Buy) (Disposition to Issuer) ($193K)
25 Oct 2016	Form 4: Bernstein Karen, Director Disposed of 30,000 Stock Option (Right to Buy) (Disposition to Issuer) ($314K)
25 Oct 2016	Form 4: Fratamico Arthur, Chief Business Officer Disposed of 13,233 shares (Tender Offer) ($278K) · Disposed of 213,423 Employee Stock Option (Right to Buy) (Disposition to Issuer) ($3.07M)
25 Oct 2016	Form 4: Santini Gino, Director Disposed of 37,000 Stock Option (Right to Buy) (Disposition to Issuer) ($421K)
25 Oct 2016	Form 4: Morris Richard Steven, Chief Financial Officer Returned 828 shares to the issuer ($17.4K) · Disposed of 237,173 Employee Stock Option (Right to Buy) (Disposition to Issuer) ($3.36M)
25 Oct 2016	Form 4: Applebaum Scott, General Counsel Disposed of 150,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) ($1.84M)
21 Oct 2016	Form 4: Gregg Richard, Chief Science Officer Received 123,902 shares by exercise or conversion ($653K)
16 Sep 2016	Form 4: Hatfield Jeffrey S., Director Sold 50,000 shares ($1.04M)
16 Sep 2016	Form 4: Adage Capital Partners GP, L.l.c., 10% owner and 4 others Sold 1,025,000 shares ($21.4M)
17 Aug 2016	Form 4: Morris Richard Steven, Chief Financial Officer Received 828 shares as a grant or award ($5.06K) · Granted 27,500 Employee Stock Option (Right to Buy)
17 Aug 2016	Form 4: Hatfield Jeffrey S., Director Received 747 shares as a grant or award ($4.56K) · Granted 60,000 Employee Stock Option (Right to Buy)
17 Aug 2016	Form 4: Fratamico Arthur, Chief Business Officer Received 2,086 shares as a grant or award ($12.7K) · Granted 14,500 Employee Stock Option (Right to Buy)
17 Aug 2016	Form 4: Gregg Richard, Chief Science Officer Received 2,100 shares as a grant or award ($12.8K) · Granted 16,500 Employee Stock Option (Right to Buy)

Comments